Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
18:47:45 EDT Thu 02 May 2024
Enter Symbol
or Name
USA
CA



Q:FOLD - AMICUS THERAPEUTICS INC - http://www.amicustherapeutics.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
FOLD - Q0.19.38·11.001.010.432,576.826,2739,21310.51  10.61  10.36514.57  9.7017:32:58May 0115 min RT 2¢

Recent Trades - Last 10 of 9213
Time ETExPriceChangeVolume
17:32:58Q10.43 226,500
16:01:45Q10.43 419
16:01:07Q10.43 1,671
16:01:01Q10.43 1,396
16:00:58Q10.43 21,562
16:00:56Q10.43 124
16:00:09Q10.43 6,240
16:00:09Q10.43 27,200
16:00:09Q10.43 7,954
16:00:06Q10.43 161,306

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-05-01 07:00U:FOLDNews ReleaseAmicus Therapeutics to Announce First Quarter 2024 Financial Results on May 9, 2024
2024-03-20 07:00U:FOLDNews ReleaseAmicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) Report
2024-03-01 07:00U:FOLDNews ReleaseAmicus Therapeutics to Present at Upcoming Investor Conferences in March 2024
2024-02-28 07:00U:FOLDNews ReleaseAmicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate Updates
2024-02-15 07:00U:FOLDNews ReleaseAmicus Therapeutics to Announce Full Year 2023 Financial Results on February 28, 2024
2024-02-08 07:00U:FOLDNews ReleaseAmicus Therapeutics Receives the 2024 New Treatment Award for Pombiliti ¢ „ ¢ (cipaglucosidase alfa-atga) + Opfolda ¢ „ ¢ (miglustat) at the 20th Annual WORLDSymposium ¢ „ ¢
2024-02-01 07:00U:FOLDNews ReleaseAmicus Therapeutics Announces Presentations and Posters at the 20th Annual WORLDSymposium ¢ „ ¢ 2024
2024-01-07 16:01U:FOLDNews ReleaseAmicus Therapeutics Reports Preliminary 2023 Revenue and Provides 2024 Strategic Outlook
2024-01-03 07:00U:FOLDNews ReleaseAmicus Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
2023-12-05 06:01U:FOLDNews ReleaseAmicus Therapeutics Congratulates Executive Chairman John F. Crowley on Appointment as Next President and CEO of BIO
2023-11-08 07:00U:FOLDNews ReleaseAmicus Therapeutics Announces Third Quarter 2023 Financial Results and Corporate Updates
2023-11-01 07:00U:FOLDNews ReleaseAmicus Therapeutics to Present at Upcoming Investor Conferences in November 2023
2023-10-27 07:00U:FOLDNews ReleaseAmicus Therapeutics to Announce Third Quarter 2023 ‚  Financial Results on November 8, 2023
2023-10-03 07:00U:FOLDNews ReleaseAmicus Therapeutics Announces Presentation and Posters at World Muscle Society 2023
2023-10-02 08:20U:FOLDNews ReleaseAmicus Therapeutics and Blackstone Enter into $430 Million Strategic Financing Collaboration
2023-09-28 10:41U:FOLDNews ReleaseAmicus Therapeutics Announces FDA Approval and Launch of New Treatment for Pompe Disease
2023-09-01 07:00U:FOLDNews ReleaseAmicus Therapeutics to Present at Upcoming Investor Conferences in September 2023
2023-08-29 07:00U:FOLDNews ReleaseAmicus Therapeutics Announces Presentation and Posters at the SSIEM Annual Symposium 2023
2023-08-21 07:00U:FOLDNews ReleaseAmicus Therapeutics Appoints Simon Harford as Chief Financial Officer
2023-08-15 07:00U:FOLDNews ReleaseAmicus Therapeutics Announces Approval and Launch ‚  of New Pompe Disease Therapy in the United Kingdom